Priority 8 from the Sight Loss and Vision PSP Age Related Macular Degeneration
|
UNCERTAINTY: Can a non-invasive therapy be developed for wet age related macular degeneration (AMD)? (JLA PSP Priority 8) |
|
|---|---|
| Overall ranking | 8 |
| JLA question ID | 0014a/8 |
| Explanatory note | No relevant systematic reviews identified at the time of the PSP |
| Evidence | No evidence at the time of the PSP |
| Health Research Classification System category | Eye |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | None provided |
| Systematic reviews that need updating or extending | None identified |
| Systematic reviews in preparation (at time of PSP) | Williams MA, McKay GJ, Chakravarthy U. Complement inhibitors for age-related macular degeneration (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD009300. DOI: 10.1002/14651858.CD009300 (in preparation at time of PSP) |
| Ongoing controlled trials |
Enrichment of macular pigment in subjects with age-related macular degeneration (AMD) ISRCTN13894787 Enhancing the therapeutic efficacy of sleep deprivation by modafinil - a double blind, randomized, placebo-controlled, monocentric phase II study https://www.clinicaltrialsregister.eu/ctr-search/search? query=eudract_number:2005-003196-21 |
| Submitted by | Patients |
| Outcomes to be measured | Change or management of in symptoms; adverse effects or complications; acceptability to the patient; and cost |
| PSP information | |
|---|---|
| PSP unique ID | 0014a |
| PSP name | Sight Loss and Vision - Age Related Macular Degeneration |
| Total number of uncertainties identified by this PSP. | 113 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | April and May 2013 |